Drug Database
Back to search

France· FR:69962719

OXALIPLATINE ARROW LAB 5 mg/mL, solution à diluer pour perfusion

A oxaliplatin product containing oxaliplatine, registered in France by EUGIA PHARMA (MALTA) (MALTE). The same ATC class is registered in 17 of our 19 countries.

ATC L01XA03

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedOXALIPLATINE ARROW LAB 5 mg/mL, solut…ATCL01XA03REGISTER NO.FR:69962719PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about oxaliplatineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Oxaliplatin is registered in 17 of 19 countries.

Countries holding a registration under ATC L01XA03 (oxaliplatin), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose
Search oxaliplatin products by name

Oxaliplatin · ATC L01XA03

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of oxaliplatin costs, country by country.

Normalised to the WHO defined daily dose (11 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Oxaliplatin · price per daily dose (11 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$24.21
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
OXALIPLATINE
Manufacturer
EUGIA PHARMA (MALTA) (MALTE)
Country
France (FR)
ATC code
L01XA03
ATC class
Oxaliplatin
Defined daily dose
11 mg, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955093022
    1 flacon en verre de 40 mL

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

740 interactions on record for oxaliplatin.

Graded by severity as the source publishes them — 101 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check oxaliplatin against other medicinesHow interaction checks work

Oxaliplatin · interactions on record

740 records

  • 101 severe
  • 453 moderate
  • 1 minor
  • 185 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxaliplatin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxaliplatin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Ebeoxal, Oxaliplatin Accord
  • Belgium · Eloxatin, Oxaliplatin Accord Healthcare
  • Bulgaria · Оксалиплатин Акорд, Оксалиплатин Булгермед
  • Cyprus · Oxaliplatin
  • Czechia · Oxaliplatin Accord, Oxaliplatin Agmed
  • Germany · Eloxatin, Medoxa
  • Denmark · Oxaliplatin Accord, Oxaliplatin Actavis
  • Estonia · Oxaliplatin Accord, Oxaliplatin Kabi
  • Spain · Oxaliplatino Accord, Oxaliplatino Aurovit
  • Finland · Oxaliplatin Accord
  • United Kingdom (Northern Ireland) · Oxaliplatin Accord Healthcare, Oxaliplatin Amarox
  • Greece · Elatofen, Oxaliplatin Deltapharma
  • Croatia · Oksaliplatin Kalceks, Oxaliplatin Kabi
  • Hungary · Oxaliplatin Accord, Oxaliplatin Kabi
  • Ireland · Oxaliplatin Accord Healthcare Ireland, Oxaliplatin Fresenius Kabi Deutschland
  • Iceland · Oxaliplatin Actrevo, Oxaliplatin Teva
  • Italy · Oxaliplatino Accord, Oxaliplatino Aurobindo
  • Lithuania · Oxaliplatin Accord, Oxaliplatin Kabi
  • Luxembourg · Eloxatin, Oxaliplatine Fresenius Kabi
  • Latvia · Oxaliplatin Accord, Oxaliplatin Kabi
  • Malta · Oxaviatin
  • Netherlands · Oxaliplatin Hikma, Oxaliplatine Accord
  • Norway · Oksaliplatin Sun, Oxaliplatin Fresenius Kabi
  • Poland · Oxaliplatin Ebewe, Oxaliplatin Eugia
  • Portugal · Oxaliplatina Accord, Oxaliplatina Aurovitas
  • Romania · Oxaliplatin Accord, Oxaliplatin Aqvida Gmbh
  • Sweden · Oxaliplatin Accord, Oxaliplatin Eugia
  • Slovenia · Oksaliplatin Kabi, Oksaliplatin Sandoz
  • Slovakia · Oxaliplatin Agmed, Oxaliplatin Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cc16c0ac-9e55-4bee-b7de-2847bcdfcc38
GET /v1/drugs/cc16c0ac-9e55-4bee-b7de-2847bcdfcc38?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "69962719",
  "date_amm": "2023-02-22",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "OXALIPLATINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution à diluer pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about oxaliplatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console